Spatial analysis revealed transcriptomic changes involving the immunomodulating gene SPP1 that has been also recently presented as a putative predictive biomarker for neoadjuvant chemotherapy in bladder cancer. The gene discussed is SPP1; the disease is urinary bladder cancer.